Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 602 | 2018 |
Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers BA Gordon, TM Blazey, J Christensen, A Dincer, S Flores, S Keefe, ... Brain 142 (4), 1063-1076, 2019 | 165 | 2019 |
Event segmentation improves event memory up to one month later. S Flores, HR Bailey, ML Eisenberg, JM Zacks Journal of Experimental Psychology: Learning, Memory, and Cognition 43 (8), 1183, 2017 | 131 | 2017 |
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ... The Lancet Neurology 21 (4), 329-341, 2022 | 124 | 2022 |
Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies Y Su, S Flores, G Wang, RC Hornbeck, B Speidel, N Joseph‐Mathurin, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11 (1 …, 2019 | 121 | 2019 |
Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies Y Su, S Flores, RC Hornbeck, B Speidel, AG Vlassenko, BA Gordon, ... NeuroImage: Clinical 19, 406-416, 2018 | 106 | 2018 |
Effects of cues to event segmentation on subsequent memory DA Gold, JM Zacks, S Flores Cognitive research: principles and implications 2, 1-15, 2017 | 103 | 2017 |
Socioeconomic Status Mediates Racial Differences Seen Using the AT (N) Framework KL Meeker, JK Wisch, D Hudson, D Coble, C Xiong, GM Babulal, ... Annals of neurology 89 (2), 254-265, 2021 | 57 | 2021 |
Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease SA Schultz, JF Strain, A Adedokun, Q Wang, O Preische, J Kuhle, S Flores, ... Neurobiology of disease 142, 104960, 2020 | 52 | 2020 |
How are false memories distinguishable from true memories in the Deese–Roediger–McDermott paradigm? A review of the findings J Jou, S Flores Psychological research 77, 671-686, 2013 | 50 | 2013 |
Dynamic prediction during perception of everyday events ML Eisenberg, JM Zacks, S Flores Cognitive research: principles and implications 3, 1-12, 2018 | 47 | 2018 |
Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease PR Millar, PH Luckett, BA Gordon, TLS Benzinger, SE Schindler, ... NeuroImage 256, 119228, 2022 | 39 | 2022 |
Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life V Thirunavu, A McCullough, Y Su, S Flores, A Dincer, JC Morris, ... Journal of Alzheimer's Disease 69 (3), 817-827, 2019 | 39 | 2019 |
Sex-related differences in tau positron emission tomography (PET) and the effects of hormone therapy (HT) JK Wisch, KL Meeker, BA Gordon, S Flores, A Dincer, EA Grant, ... Alzheimer Disease & Associated Disorders 35 (2), 164-168, 2021 | 38 | 2021 |
Etiology of white matter hyperintensities in autosomal dominant and sporadic Alzheimer disease Z Shirzadi, SA Schultz, WYW Yau, N Joseph-Mathurin, CD Fitzpatrick, ... JAMA neurology 80 (12), 1353-1363, 2023 | 29 | 2023 |
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study AH Boerwinkle, BA Gordon, J Wisch, S Flores, RL Henson, OH Butt, ... The Lancet Neurology 22 (1), 55-65, 2023 | 29 | 2023 |
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease A Dincer, BA Gordon, A Hari-Raj, SJ Keefe, S Flores, NS McKay, ... NeuroImage: Clinical 28, 102491, 2020 | 28 | 2020 |
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease YY Lim, P Maruff, NR Barthélemy, A Goate, J Hassenstab, C Sato, ... JAMA neurology 79 (3), 261-270, 2022 | 27 | 2022 |
Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease AH Boerwinkle, JK Wisch, CD Chen, BA Gordon, OH Butt, SE Schindler, ... Neurology 97 (1), e76-e87, 2021 | 27 | 2021 |
Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease N Joseph‐Mathurin, JJ Llibre‐Guerra, Y Li, AA McCullough, C Hofmann, ... Annals of neurology 92 (5), 729-744, 2022 | 26 | 2022 |